|
1
|
Farhat FS and Houhou W: Targeted therapies
in non-small cell lung carcinoma: What have we achieved so far?
Ther Adv Med Oncol. 5:249–270. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tian ZQ, Li ZH, Wen SW, Zhang YF, Li Y,
Cheng JG and Wang GY: Identification of commonly dysregulated genes
in non-small-cell lung cancer by integrated analysis of microarray
data and qRT-PCR validation. Lung. 193:583–592. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Q, Yu Z, Xiang Y, Wu N, Wu L, Xu B,
Wang L, Yang P, Li Y and Bai L: Prognostic and predictive
significance of thymidylate synthase protein expression in
non-small cell lung cancer: A systematic review and meta-analysis.
Cancer Biomark. 15:65–78. 2015.
|
|
4
|
Wang Y, Chen J, Wu S, Hu C, Li X, Wang Y,
Yang Y, Rajan N, Chen Y, Chen Y, et al: Clinical effectiveness and
clinical toxicity associated with platinum-based doublets in the
first-line setting for advanced non-squamous non-small cell lung
cancer in Chinese patients: A retrospective cohort study. BMC
Cancer. 14:9402014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsai MF, Wang CC and Chen JJ: Tumour
suppressor HLJ1: A potential diagnostic, preventive and therapeutic
target in non-small cell lung cancer. World J Clin Oncol.
5:865–873. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Isa T, Tomita S, Nakachi A, Miyazato H,
Shimoji H, Kusano T, Muto Y and Furukawa M: Analysis of
microsatellite instability, K-ras gene mutation and p53 protein
overexpression in intrahepatic cholangiocarcinoma.
Hepatogastroenterology. 49:604–608. 2002.PubMed/NCBI
|
|
7
|
Gu A, Lu J, Wang W, Shi C, Han B and Yao
M: Role of miR-497 in VEGF-A-mediated cancer cell growth and
invasion in non-small cell lung cancer. Int J Biochem Cell Biol.
70:118–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma GF, Zhang RF, Ying KJ and Wang D:
Effect evaluation of cisplatin-gemcitabine combination chemotherapy
for advanced non-small cell lung cancer patients using microarray
data. Eur Rev Med Pharmacol Sci. 19:578–585. 2015.PubMed/NCBI
|
|
9
|
Guo W, Xie L, Zhao L and Zhao Y: mRNA and
microRNA expression profiles of radioresistant NCI-H520 non-small
cell lung cancer cells. Mol Med Rep. 12:1857–1867. 2015.PubMed/NCBI
|
|
10
|
Der SD, Sykes J, Pintilie M, Zhu CQ,
Strumpf D, Liu N, Jurisica I, Shepherd FA and Tsao MS: Validation
of a histology-independent prognostic gene signature for
early-stage, non-small-cell lung cancer including stage IA
patients. J Thorac Oncol. 9:59–64. 2014. View Article : Google Scholar
|
|
11
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy - analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Diboun I, Wernisch L, Orengo CA and
Koltzenburg M: Microarray analysis after RNA amplification can
detect pronounced differences in gene expression using limma. BMC
Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan X, Jiang Z, Bi L, Yang Y and Chen W:
Salvianolic acid A attenuates TNF-α- and D-GalN-induced ER
stress-mediated and mitochondrial-dependent apoptosis by modulating
Bax/Bcl-2 ratio and calcium release in hepatocyte LO2 cells. Naunyn
Schmiedebergs Arch Pharmacol. 388:817–830. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen J, Bardes EE, Aronow BJ and Jegga AG:
ToppGene Suite for gene list enrichment analysis and candidate gene
prioritization. Nucleic Acids Res. 37:W305–W311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nogales-Cadenas R, Carmona-Saez P, Vazquez
M, Vicente C, Yang X, Tirado F, Carazo JM and Pascual-Montano A:
GeneCodis: Interpreting gene lists through enrichment analysis and
integration of diverse biological information. Nucleic Acids Res.
37:W317–W322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Becker T, Gerke V, Kube E and Weber K:
S100P, a novel Ca(2+)-binding protein from human placenta. cDNA
cloning, recombinant protein expression and Ca2+ binding
properties. Eur J Biochem. 207:541–547. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang H, Wang G, Ding Y, Wang Z,
Barraclough R, Rudland PS, Fernig DG and Rao Z: The crystal
structure at 2A resolution of the Ca2+ -binding protein
S100P. J Mol Biol. 325:785–794. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bartling B, Rehbein G, Simm A, Silber RE
and Hofmann HS: Porcupine expression is associated with the
expression of S100P and other cancer-related molecules in non-small
cell lung carcinoma. Int J Oncol. 36:1015–1021. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Magnusson LU, Lundqvist A, Karlsson MN,
Skålén K, Levin M, Wiklund O, Borén J and Hultén LM: Arachidonate
15-lipoxygenase type B knockdown leads to reduced lipid
accumulation and inflammation in atherosclerosis. PLoS One.
7:e431422012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tschopp J, Martinon F and Burns K: NALPs:
A novel protein family involved in inflammation. Nat Rev Mol Cell
Biol. 4:95–104. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan KS, Sano S, Kiguchi K, Anders J,
Komazawa N, Takeda J and DiGiovanni J: Disruption of Stat3 reveals
a critical role in both the initiation and the promotion stages of
epithelial carcinogenesis. J Clin Invest. 114:720–728. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moore RJ, Owens DM, Stamp G, Arnott C,
Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M,
et al: Mice deficient in tumor necrosis factor-α are resistant to
skin carcinogenesis. Nat Med. 5:828–831. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Menzies-Gow A, Ying S, Sabroe I, Stubbs
VL, Soler D, Williams TJ and Kay AB: Eotaxin (CCL11) and eotaxin-2
(CCL24) induce recruitment of eosinophils, basophils, neutrophils,
and macrophages as well as features of early- and late-phase
allergic reactions following cutaneous injection in human atopic
and nonatopic volunteers. J Immunol. 169:2712–2718. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Campbell EM, Kunkel SL, Strieter RM and
Lukacs NW: Temporal role of chemokines in a murine model of
cockroach allergen-induced airway hyperreactivity and eosinophilia.
J Immunol. 161:7047–7053. 1998.PubMed/NCBI
|
|
26
|
Yawalkar N, Uguccioni M, Schärer J,
Braunwalder J, Karlen S, Dewald B, Braathen LR and Baggiolini M:
Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J
Invest Dermatol. 113:43–48. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu MM, Mao GX, Liu J, Li JC, Huang H, Liu
YF and Liu JH: Low expression of the FoxO4 gene may contribute to
the phenomenon of EMT in non-small cell lung cancer. Asian Pac J
Cancer Prev. 15:4013–4018. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su L, Liu X, Chai N, Lv L, Wang R, Li X,
Nie Y, Shi Y and Fan D: The transcription factor FOXO4 is
down-regulated and inhibits tumor proliferation and metastasis in
gastric cancer. BMC Cancer. 14:3782014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu XQ, Tang SH, Zhang ZY and Jin HF:
Expression and clinical significance of FOX04 in colorectal cancer.
Chinese J Cell Mol Immunol. 27:969–971. 2011.In Chinese.
|
|
30
|
Salic K and De Windt LJ: MicroRNAs as
biomarkers for myocardial infarction. Curr Atheroscler Rep.
14:193–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang WC, Chan SH, Jang TH, Chang JW, Ko
YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, et al:
miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral
squamous cell carcinoma invasion and metastasis. Cancer Res.
74:751–764. 2014. View Article : Google Scholar
|
|
32
|
Zhou Y, Li Y, Ye J, Jiang R, Yan H, Yang
X, Liu Q and Zhang J: MicroRNA-491 is involved in metastasis of
hepatocellular carcinoma by inhibitions of matrix metalloproteinase
and epithelial to mesenchymal transition. Liver Int. 33:1271–1280.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mowla SJ, Naeli P, Mirzadeh AF and
Tavallaei M: Evaluating the expression of miR-491 as a potential
stemness marker in lung tumor and non-tumor tissue. Cell J
(Yakhteh). 15(Suppl 1): 632013.
|
